4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity

Journal of Alzheimer's Disease : JAD
Young Jung LeeJin Tae Hong

Abstract

Alzheimer's disease (AD), the most common form of dementia, is characterized by memory deficits and deposition of amyloid-β (Aβ) in the brain. It has been known that neuroinflammation and oxidative stress are critical factors in the development of AD. 4-O-methylhonokiol, an extract from Magnolia officinalis, is known to have anti-inflammatory and anti-oxidative effects. Thus, we investigated the properties of 4-O-methylhonokiol against progression and development of AD in Tg2576 mice. Tg2576 mice models show memory impairment and AD-like pathological features including Aβ deposition. Oral administration of 4-O-methylhonokiol through drinking water (1 mg/kg in 0.0002% Tween 80) for 12 weeks not only prevented memory impairment but also inhibited Aβ deposition. In addition, 4-O-methylhonokiol decreased β-secretase activity, oxidative lipid and protein damage levels, activation of astrocytes and microglia cells, and generation of IL-1β and TNF-α with increase of glutathione level in the brain. Our results showed that 4-O-methylhonokiol effectively prevented memory impairment by down-regulating β-secretase activity through inhibition of oxidative stress and neuroinflammatory responses in Tg2576 transgenic mice.

Citations

Jun 22, 2012·Journal of Neuroinflammation·Jürg Gertsch, Sharon Anavi-Goffer
Jun 23, 2018·Biomolecules & Therapeutics·Zhenzhen HuKi-Wan Oh
May 29, 2018·Reviews in the Neurosciences·Ghazaleh KheiriNima Rezaei
Sep 13, 2013·Future Medicinal Chemistry·Wei Zhou, Wenhui Hu
Dec 2, 2014·Expert Opinion on Therapeutic Targets·Patrick L McGeer, Edith G McGeer
Jul 10, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Eleonora PatsenkerFelix Stickel
Jul 5, 2013·Phytotherapy Research : PTR·Hyung Eun YuKiho Lee
Feb 1, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Santu K SinghaZia Shariat-Madar
Jan 28, 2021·International Journal of Molecular Sciences·Ana Lago-FernandezPaula Morales
May 10, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Prajakta A DhageShidin Balakrishnan
Jun 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ou QiaoWenyuan Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.